"It is a mandibular advancement splint that was way too expensive for pratitioners. So to get around that they used a ema mandibular advancement splint design (buccal elastic straps) and printed it to save money. Nothing new there."
We know all that, anyone who has researched OVN, whats your point Quakka?. My understanding is OVN's device has the highest efficacy next to the gold standard cpap masks. Resmed and others are doing very well despite the 50% plus of users who discontinue in the first year. USA Govt Health part funds them and with the consumables and replacement every three years OVN's revenue will be great as long as they continue signing up sleep centres etc.
Can you back up your last paragraph, sounds interesting , if you have the evidence, thanks.D
- Forums
- ASX - By Stock
- OVN
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-68
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OVN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online